BEAM
Price
$23.44
Change
+$0.04 (+0.17%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
1.94B
45 days until earnings call
SCPH
Price
$3.27
Change
-$0.15 (-4.39%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
164.13M
60 days until earnings call
Ad is loading...

BEAM vs SCPH

Header iconBEAM vs SCPH Comparison
Open Charts BEAM vs SCPHBanner chart's image
Beam Therapeutics
Price$23.44
Change+$0.04 (+0.17%)
Volume$15.99K
Capitalization1.94B
scPharmaceuticals
Price$3.27
Change-$0.15 (-4.39%)
Volume$2.31K
Capitalization164.13M
BEAM vs SCPH Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. SCPH commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and SCPH is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (BEAM: $23.40 vs. SCPH: $3.42)
Brand notoriety: BEAM and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 75% vs. SCPH: 34%
Market capitalization -- BEAM: $1.94B vs. SCPH: $164.13M
BEAM [@Biotechnology] is valued at $1.94B. SCPH’s [@Biotechnology] market capitalization is $164.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while SCPH’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 6 bearish.
  • SCPH’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -12.69% price change this week, while SCPH (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

SCPH is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.94B) has a higher market cap than SCPH($164M). SCPH YTD gains are higher at: -3.390 vs. BEAM (-5.645). SCPH has higher annual earnings (EBITDA): -71.31M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. SCPH (91.5M). SCPH has less debt than BEAM: SCPH (52.5M) vs BEAM (162M). BEAM has higher revenues than SCPH: BEAM (350M) vs SCPH (30.3M).
BEAMSCPHBEAM / SCPH
Capitalization1.94B164M1,184%
EBITDA-160.83M-71.31M226%
Gain YTD-5.645-3.390167%
P/E RatioN/AN/A-
Revenue350M30.3M1,155%
Total Cash926M91.5M1,012%
Total Debt162M52.5M309%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMSCPH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.04%
CRSP - BEAM
70%
Closely correlated
+3.23%
NTLA - BEAM
62%
Loosely correlated
-2.99%
DNLI - BEAM
61%
Loosely correlated
+0.79%
PRME - BEAM
60%
Loosely correlated
+0.35%
RXRX - BEAM
59%
Loosely correlated
-0.31%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with MGTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
-2.29%
MGTX - SCPH
44%
Loosely correlated
+3.85%
PLRX - SCPH
44%
Loosely correlated
-8.16%
AURA - SCPH
43%
Loosely correlated
-0.78%
BEAM - SCPH
43%
Loosely correlated
+0.04%
XERS - SCPH
43%
Loosely correlated
-0.62%
More